Literature DB >> 22222875

Immunomodulatory functions of type I interferons.

José M González-Navajas1, Jongdae Lee, Michael David, Eyal Raz.   

Abstract

Interferon-α (IFNα) and IFNβ, collectively known as type I IFNs, are the major effector cytokines of the host immune response against viral infections. However, the production of type I IFNs is also induced in response to bacterial ligands of innate immune receptors and/or bacterial infections, indicating a broader physiological role for these cytokines in host defence and homeostasis than was originally assumed. The main focus of this Review is the underappreciated immunomodulatory functions of type I IFNs in health and disease. We discuss their function in the regulation of innate and adaptive immune responses, the response to bacterial ligands, inflammasome activation, intestinal homeostasis and inflammatory and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22222875      PMCID: PMC3727154          DOI: 10.1038/nri3133

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  148 in total

Review 1.  Critical review: assessment of interferon-β immunogenicity in multiple sclerosis.

Authors:  Klaus Bendtzen
Journal:  J Interferon Cytokine Res       Date:  2010-10       Impact factor: 2.607

Review 2.  Induction of type I interferons by bacteria.

Authors:  Kathryn M Monroe; Sarah M McWhirter; Russell E Vance
Journal:  Cell Microbiol       Date:  2010-05-06       Impact factor: 3.715

3.  T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells.

Authors:  Claudia Hofmann; Nadja Dunger; Nicole Grunwald; Günter J Hämmerling; Petra Hoffmann; Jürgen Schölmerich; Werner Falk; Florian Obermeier
Journal:  Gut       Date:  2010-08-23       Impact factor: 23.059

Review 4.  Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity.

Authors:  Paola Rizza; Franca Moretti; Filippo Belardelli
Journal:  Autoimmunity       Date:  2010-04       Impact factor: 2.815

5.  Type I IFN signaling constrains IL-17A/F secretion by gammadelta T cells during bacterial infections.

Authors:  Thomas Henry; Girish S Kirimanjeswara; Thomas Ruby; Jonathan W Jones; Kaitian Peng; Magali Perret; Lena Ho; John-Demian Sauer; Yoichiro Iwakura; Dennis W Metzger; Denise M Monack
Journal:  J Immunol       Date:  2010-02-22       Impact factor: 5.422

6.  The role of glycogen synthase kinase 3 in regulating IFN-β-mediated IL-10 production.

Authors:  Huizhi Wang; Jonathan Brown; Carlos A Garcia; Yunan Tang; Manjunatha R Benakanakere; Terrance Greenway; Pascale Alard; Denis F Kinane; Michael Martin
Journal:  J Immunol       Date:  2010-12-15       Impact factor: 5.422

Review 7.  Type I interferon: friend or foe?

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

8.  Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.

Authors:  Jose M González-Navajas; Jason Law; Kim Phung Nguyen; Meha Bhargava; Mary Patricia Corr; Nissi Varki; Lars Eckmann; Hal M Hoffman; Jongdae Lee; Eyal Raz
Journal:  J Exp Med       Date:  2010-11-29       Impact factor: 14.307

9.  The AIM2 inflammasome is critical for innate immunity to Francisella tularensis.

Authors:  Teresa Fernandes-Alnemri; Je-Wook Yu; Christine Juliana; Leobaldo Solorzano; Seokwon Kang; Jianghong Wu; Pinaki Datta; Margaret McCormick; Lan Huang; Erin McDermott; Laurence Eisenlohr; Carlisle P Landel; Emad S Alnemri
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

10.  Type I interferon signaling is required for activation of the inflammasome during Francisella infection.

Authors:  Thomas Henry; Anna Brotcke; David S Weiss; Lucinda J Thompson; Denise M Monack
Journal:  J Exp Med       Date:  2007-04-23       Impact factor: 14.307

View more
  410 in total

Review 1.  Dissecting immunity by germline mutagenesis.

Authors:  Onjee Choi; Sophie Rutschmann
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

Review 2.  Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination.

Authors:  Christophe J Desmet; Ken J Ishii
Journal:  Nat Rev Immunol       Date:  2012-06-22       Impact factor: 53.106

3.  Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression.

Authors:  Yawara Kawano; Oksana Zavidij; Jihye Park; Michele Moschetta; Katsutoshi Kokubun; Tarek H Mouhieddine; Salomon Manier; Yuji Mishima; Naoka Murakami; Mark Bustoros; Romanos Sklavenitis Pistofidis; Mairead Reidy; Yu J Shen; Mahshid Rahmat; Pavlo Lukyanchykov; Esilida Sula Karreci; Shokichi Tsukamoto; Jiantao Shi; Satoshi Takagi; Daisy Huynh; Antonio Sacco; Yu-Tzu Tai; Marta Chesi; P Leif Bergsagel; Aldo M Roccaro; Jamil Azzi; Irene M Ghobrial
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

Review 4.  Decoding the complexity of type I interferon to treat persistent viral infections.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Trends Microbiol       Date:  2013-11-08       Impact factor: 17.079

5.  Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses.

Authors:  Xuanming Yang; Xunmin Zhang; May Lynne Fu; Ralph R Weichselbaum; Thomas F Gajewski; Yajun Guo; Yang-Xin Fu
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

6.  Mint3 potentiates TLR3/4- and RIG-I-induced IFN-β expression and antiviral immune responses.

Authors:  Wanwan Huai; Hui Song; Zhongxia Yu; Wenwen Wang; Lihui Han; Takeharu Sakamoto; Motoharu Seiki; Lining Zhang; Qunye Zhang; Wei Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

7.  Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons.

Authors:  Isabella Rauch; Felix Rosebrock; Eva Hainzl; Susanne Heider; Andrea Majoros; Sebastian Wienerroither; Birgit Strobl; Silvia Stockinger; Lukas Kenner; Mathias Müller; Thomas Decker
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

8.  Aryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon.

Authors:  Qinjie Zhou; Alfonso Lavorgna; Melissa Bowman; John Hiscott; Edward W Harhaj
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

Review 9.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

10.  Sirtuin 2-mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I interferon responses.

Authors:  Ewa M Kosciuczuk; Swarna Mehrotra; Diana Saleiro; Barbara Kroczynska; Beata Majchrzak-Kita; Pawel Lisowski; Caroline Driehaus; Anna Rogalska; Acara Turner; Thomas Lienhoop; David Gius; Eleanor N Fish; Athanassios Vassilopoulos; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2018-11-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.